| Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors C Valero, M Lee, D Hoen, K Weiss, DW Kelly, PS Adusumilli, PK Paik, ... Nature communications 12 (1), 729, 2021 | 242 | 2021 |
| The association between tumor mutational burden and prognosis is dependent on treatment context C Valero, M Lee, D Hoen, J Wang, Z Nadeem, N Patel, MA Postow, ... Nature genetics 53 (1), 11-15, 2021 | 161 | 2021 |
| Improved prediction of immune checkpoint blockade efficacy across multiple cancer types D Chowell, SK Yoo, C Valero, A Pastore, C Krishna, M Lee, D Hoen, ... Nature biotechnology 40 (4), 499-506, 2022 | 147 | 2022 |
| The immune microenvironment and neoantigen landscape of aggressive salivary gland carcinomas differ by subtype M Linxweiler, F Kuo, N Katabi, M Lee, Z Nadeem, MG Dalin, V Makarov, ... Clinical Cancer Research 26 (12), 2859-2870, 2020 | 88 | 2020 |
| Changes in trends in thyroid cancer incidence in the United States, 1992 to 2016 AE Powers, AR Marcadis, M Lee, LGT Morris, JL Marti Jama 322 (24), 2440-2441, 2019 | 88 | 2019 |
| Tumor mutational burden as a predictive biomarker for checkpoint inhibitor immunotherapy M Lee, RM Samstein, C Valero, TA Chan, LGT Morris Human vaccines & immunotherapeutics 16 (1), 112-115, 2020 | 65 | 2020 |
| Functional landscapes of POLE and POLD1 mutations in checkpoint blockade-dependent antitumor immunity X Ma, N Riaz, RM Samstein, M Lee, V Makarov, C Valero, D Chowell, ... Nature genetics 54 (7), 996-1012, 2022 | 36 | 2022 |
| Is office laryngoscopy an aerosol‐generating procedure? A Rameau, M Lee, N Enver, L Sulica The Laryngoscope 130 (11), 2637-2642, 2020 | 35 | 2020 |
| Longitudinal prediction of suicide attempts for a diverse adolescent sample of native Hawaiians, Pacific peoples, and Asian Americans ES Hishinuma, MD Smith, K McCarthy, M Lee, DA Goebert, ... Archives of Suicide Research 22 (1), 67-90, 2018 | 32 | 2018 |
| Assessment of screening mammography recommendations by breast cancer centers in the US NS Patel, M Lee, JL Marti JAMA Internal Medicine 181 (5), 717-719, 2021 | 23 | 2021 |
| High response rate and durability driven by HLA genetic diversity in patients with kidney cancer treated with lenvatinib and pembrolizumab CH Lee, RG DiNatale, D Chowell, C Krishna, V Makarov, C Valero, ... Molecular Cancer Research 19 (9), 1510-1521, 2021 | 21 | 2021 |
| Reversal in thyroid cancer incidence trends in the United States, 2000–2017 M Lee, AE Powers, LGT Morris, JL Marti Thyroid 30 (8), 1226, 2020 | 18 | 2020 |
| Patterns of recurrence of phonotraumatic vocal fold lesions suggest distinct mechanisms of injury M Lee, T Mau, L Sulica The Laryngoscope 131 (11), 2523-2529, 2021 | 16 | 2021 |
| Genomic and transcriptomic correlates of thyroid carcinoma evolution after BRAF inhibitor therapy M Lee, BR Untch, B Xu, R Ghossein, C Han, F Kuo, C Valero, Z Nadeem, ... Molecular Cancer Research 20 (1), 45-55, 2022 | 14 | 2022 |
| TERT Promoter Mutations Are Enriched in Oral Cavity Cancers and Associated With Locoregional Recurrence Y Yu, D Fan, X Song, K Zakeri, L Chen, J Kang, S McBride, CJ Tsai, ... JCO Precision Oncology 5, 1259-1269, 2021 | 14 | 2021 |
| Towards an immersive learning knowledge tree-a conceptual framework for mapping knowledge and tools in the field D Beck, L Morgado, M Lee, C Gütl, A Dengel, M Wang, S Warren, ... 2021 7th International Conference of the Immersive Learning Research Network …, 2021 | 14 | 2021 |
| An Open‐Source Three‐Dimensionally Printed Laryngeal Model for Injection Laryngoplasty Training M Lee, C Ang, K Andreadis, J Shin, A Rameau The Laryngoscope 131 (3), E890-E895, 2021 | 13 | 2021 |
| Recurrence of benign phonotraumatic vocal fold lesions after microlaryngoscopy M Lee, L Sulica The Laryngoscope 130 (8), 1989-1995, 2020 | 13 | 2020 |
| Association between toxic effects and survival in patients with cancer and autoimmune disease treated with checkpoint inhibitor immunotherapy CY Han, C Fitzgerald, M Lee, C Valero, M Gönen, A Shoushtari, ... JAMA oncology 8 (9), 1352-1354, 2022 | 12 | 2022 |
| Clinical-genomic determinants of immune checkpoint blockade response in head and neck squamous cell carcinoma C Valero, M Golkaram, JL Vos, B Xu, C Fitzgerald, M Lee, S Kaplan, ... The Journal of Clinical Investigation 133 (19), 2023 | 5 | 2023 |
